We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
-$289M
(-12%)
Cap. Flow
-$380M
Cap. Flow
% of AUM
-18.22%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
697
New
113
Increased
76
Reduced
358
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$11.6M |
| 2 |
Phillips 66
PSX
|
+$11.1M |
| 3 |
MetLife
MET
|
+$10.1M |
| 4 |
Macy's
M
|
+$9.08M |
| 5 |
O'Reilly Automotive
ORLY
|
+$8.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$10.7M |
| 3 |
GAP
The Gap Inc
GAP
|
+$8.4M |
| 4 |
United Airlines
UAL
|
+$8.14M |
| 5 |
SKX
Skechers
SKX
|
+$7.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.17% |
| 2 | Industrials | 14.75% |
| 3 | Technology | 13.58% |
| 4 | Healthcare | 12.19% |
| 5 | Financials | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Texas Instruments
TXN
$248B
| $12.1M | 0.58% |
253,251
-3,803
| -1% | -$178K |
|
|
27
US Bancorp
USB
$97.9B
| $12.1M | 0.58% |
+279,044
| New | +$11.6M |
|
28
3M
MMM
$91.8B
| $12.1M | 0.58% |
100,807
-7,317
| -7% | -$859K |
|
29
Deere & Co
DE
$165B
| $12.1M | 0.58% |
133,307
+40,523
| +44% | +$3.73M |
|
30
Merck
MRK
$322B
| $12M | 0.58% |
218,226
-15,045
| -6% | -$821K |
|
31
Procter & Gamble
PG
$340B
| $12M | 0.58% |
152,926
+1,967
| +1% | +$159K |
|
32
McDonald's
MCD
$193B
| $12M | 0.58% |
119,069
-5,390
| -4% | -$544K |
|
33
General Motors
GM
$80.9B
| $12M | 0.57% |
330,304
+33,305
| +11% | +$1.16M |
|
34
Verizon
VZ
$197B
| $12M | 0.57% |
245,032
-9,614
| -4% | -$466K |
|
35
Colgate-Palmolive
CL
$74.8B
| $12M | 0.57% |
175,525
-13,562
| -7% | -$909K |
|
36
Chevron
CVX
$382B
| $11.9M | 0.57% |
91,532
-11,798
| -11% | -$1.47M |
|
37
GE Aerospace
GE
$364B
| $11.9M | 0.57% |
94,851
-3,451
| -4% | -$439K |
|
38
Altria Group
MO
$125B
| $11.9M | 0.57% |
284,790
-41,483
| -13% | -$1.67M |
|
39
Walmart Inc
WMT
$909B
| $11.9M | 0.57% |
477,123
+9,261
| +2% | +$238K |
|
40
Target
TGT
$66.3B
| $11.9M | 0.57% |
205,832
+52,445
| +34% | +$3.09M |
|
41
Boeing
BA
$169B
| $11.9M | 0.57% |
93,556
-3,433
| -4% | -$448K |
|
42
DuPont de Nemours
DD
$18.6B
| $11.9M | 0.57% |
91,191
-3,049
| -3% | -$389K |
|
43
ExxonMobil
XOM
$650B
| $11.8M | 0.57% |
117,402
-9,088
| -7% | -$917K |
|
44
NOV
NOV
$6.84B
| $11.3M | 0.54% |
137,494
+83,877
| +156% | +$6.25M |
|
45
Wynn Resorts
WYNN
$10.3B
| $11.2M | 0.54% |
54,168
+34,892
| +181% | +$7.23M |
|
|
DD
46
DELISTED
Du Pont De Nemours E I
DD
| $11M | 0.53% |
177,630
-11,949
| -6% | -$768K |
|
|
HBI
47
DELISTED
Hanesbrands
HBI
| $10.9M | 0.52% |
443,880
-115,400
| -21% | -$2.38M |
|
|
48
Phillips 66
PSX
$82.9B
| $10.8M | 0.52% |
+134,256
| New | +$11.1M |
|
|
49
MetLife
MET
$62.4B
| $10.7M | 0.51% |
+216,590
| New | +$10.1M |
|
50
Capri Holdings
CPRI
$1.82B
| $9.98M | 0.48% |
112,563
+64,200
| +133% | +$5.9M |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Cadence Capital Management held 697 positions worth $2.09B, down 12% from $2.37B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Cadence Capital Management withdrew a net $380M in Q2 2014, closing 150 positions and reducing 358 holdings. Its most notable exit was Alnylam Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.
Against the trend, Cadence Capital Management opened a new position in US Bancorp worth $12.1M.
- Cadence Capital Management's largest Q2 2014 buy was US Bancorp: 279,044 shares worth $12.1M.
- Cadence Capital Management added most to Wynn Resorts in Q2 2014, an estimated $7.23M increase.
- Cadence Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $17.7M.
- Cadence Capital Management fully exited Alnylam Pharmaceuticals in Q2 2014, selling an estimated $10.7M.
- Cadence Capital Management's ten largest holdings make up 8.3% of its $2.09B portfolio in Q2 2014.
- Cadence Capital Management opened 113 new positions and closed 150 in Q2 2014.
- Cadence Capital Management's portfolio value fell 12% quarter-over-quarter to $2.09B.
Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.